SCHEMBL7943995

SCHEMBL7943995

CCCn1c(=O)c(-c2nccs2)nc2c(N)cc(NCC)nc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSF1 Q00613 1/20 0.36
CYP1A2 P05177 10/20 0.34
CASP1 P29466 10/20 0.34
CASP7 P55210 10/20 0.34
HSD17B10 Q99714 10/20 0.34
USP2 O75604 9/20 0.34
CYP3A4 P08684 9/20 0.34
ALDH1A1 P00352 9/20 0.34
HIF1A Q16665 9/20 0.34
MEN1 O00255 6/20 0.34
KMT2A Q03164 6/20 0.34
CYP2D6 P10635 6/20 0.34
CYP2C9 P11712 5/20 0.34
CLK4 Q9HAZ1 3/20 0.34
MAPK1 P28482 3/20 0.34
LMNA P02545 3/20 0.34
GLA P06280 3/20 0.34
TSHR P16473 3/20 0.34
ADORA1 P30542 2/20 0.34
ADORA3 P0DMS8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7937747 0.93 HSF1 (0.35) HSF1CYP1A2CASP1CASP7HSD17B10
SCHEMBL7944574 0.91 HSF1 (0.36) HSF1ADORA1ADORA3ADORA2ALYN
SCHEMBL7937752 0.86 ADORA2A (0.39) HSF1CYP1A2CASP1CASP7HSD17B10
SCHEMBL7944078 0.81 PDE4B (0.42) HSF1CYP1A2CASP1CASP7HSD17B10
SCHEMBL7937864 0.78 ADORA2A (0.38) CYP1A2CASP1CASP7HSD17B10USP2
SCHEMBL7946794 0.76 ADORA1 (0.39) HSF1ADORA1ADORA3ADORA2ALYN
SCHEMBL7945987 0.76 TYRO3 (0.36) HSF1CYP1A2CASP1CASP7HSD17B10
SCHEMBL7944114 0.75 PDE4B (0.48) HSF1CYP1A2CYP3A4CYP2C9ADORA1
SCHEMBL7947006 0.72 ALDH1A1 (0.34) CYP1A2CASP1CASP7HSD17B10USP2
SCHEMBL7947184 0.70 CYP1A2 (0.45) CYP1A2CASP1CASP7HSD17B10USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010008775-A1 AMINOPYRIDOPYRAZINONE DERIVATIVES FOR TREATING NEURODEGENERATIVE DISEASES LIGAND PHARMACEUTICALS INC. (US) 2010-01-21 WO disclosed